Chagas disease is an emerging infection in Italy as the consequence of the huge immigration from Latin American countries observed during the last ten-fifteen years. However, the interest of Italian researchers on Chagas disease dates back to the '80-90s of the last century with studies conducted in collaboration with Brazilian and Argentinian colleagues by Italian cardiologists and pathologists. Moreover, the first demonstration of the existence in the pre-Columbian America of Chagas disease in a Peruvian mummy was made by a group of Italian paleopathologists. Seroprevalence studies performed between 2010-2014 in Negrar (Verona), Bergamo, Milan, Florence and Rome shows T. cruzi infection ranging from 3.9% to 17.1% with people coming from Bolivia as the most affected. As observed in Latin America about 30% of screened subjects in Italy are affected by cardiac or digestive forms of Chagas disease. More than 20% of subjects treated with benznidazole discontinued it permanently due to adverse events.

A review of Chagas disease in Italy and the study's contribution of Italian researchers / S. Antinori, A. Ridolfo, A. Giacomelli, C.M. Bonazzetti, M. Corbellino, M. Galli. - In: PANMINERVA MEDICA. - ISSN 0031-0808. - (2019). [Epub ahead of print] [10.23736/S0031-0808.19.03723-6]

A review of Chagas disease in Italy and the study's contribution of Italian researchers

S. Antinori
Primo
;
A. Giacomelli;C.M. Bonazzetti;M. Galli
2019

Abstract

Chagas disease is an emerging infection in Italy as the consequence of the huge immigration from Latin American countries observed during the last ten-fifteen years. However, the interest of Italian researchers on Chagas disease dates back to the '80-90s of the last century with studies conducted in collaboration with Brazilian and Argentinian colleagues by Italian cardiologists and pathologists. Moreover, the first demonstration of the existence in the pre-Columbian America of Chagas disease in a Peruvian mummy was made by a group of Italian paleopathologists. Seroprevalence studies performed between 2010-2014 in Negrar (Verona), Bergamo, Milan, Florence and Rome shows T. cruzi infection ranging from 3.9% to 17.1% with people coming from Bolivia as the most affected. As observed in Latin America about 30% of screened subjects in Italy are affected by cardiac or digestive forms of Chagas disease. More than 20% of subjects treated with benznidazole discontinued it permanently due to adverse events.
No
English
Settore MED/17 - Malattie Infettive
Articolo
Esperti anonimi
Pubblicazione scientifica
2019
30-lug-2019
Epub ahead of print
Periodico con rilevanza internazionale
Aderisco
info:eu-repo/semantics/article
A review of Chagas disease in Italy and the study's contribution of Italian researchers / S. Antinori, A. Ridolfo, A. Giacomelli, C.M. Bonazzetti, M. Corbellino, M. Galli. - In: PANMINERVA MEDICA. - ISSN 0031-0808. - (2019). [Epub ahead of print] [10.23736/S0031-0808.19.03723-6]
reserved
Prodotti della ricerca::01 - Articolo su periodico
6
262
Article (author)
no
S. Antinori, A. Ridolfo, A. Giacomelli, C.M. Bonazzetti, M. Corbellino, M. Galli
File in questo prodotto:
File Dimensione Formato  
Panminerva Med-3723_Bozza in PDF_V3_2019-11-18.pdf

accesso riservato

Tipologia: Publisher's version/PDF
Dimensione 1 MB
Formato Adobe PDF
1 MB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/691026
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 5
  • ???jsp.display-item.citation.isi??? 3
social impact